<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00160 Mid Day Pyqs (Neetpg-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">25</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 57284,
    "choices": [
      {
        "id": 228517,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></p>"
      },
      {
        "id": 228518,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisoprolol</span></span></p>"
      },
      {
        "id": 228519,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol</span></span></p>"
      },
      {
        "id": 228520,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pindolol</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following cardioselective beta-blockers has been shown to decrease mortality in patients with congestive heart failure? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q8178878",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947625,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bisoprolol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisoprolol is a cardioselective beta-blocker that has been clinically proven to reduce mortality in patients with chronic congestive heart failure (CHF). It works by decreasing the heart rate, reducing myocardial oxygen demand, and limiting the harmful effects of sympathetic nervous system activation in heart failure. Along with <strong>metoprolol and carvedilol, bisoprolol</strong> is one of the few beta-blockers approved for use in CHF due to its demonstrated benefits in reducing mortality and improving patient outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember - Drugs that decrease mortality are primarily those that inhibit the renin-angiotensin pathway, including beta blockers, ACE inhibitors, ARBs (angiotensin II receptor blockers), and angiotensin receptor blockers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Propranolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a non-selective beta-blocker and is not typically used in the management of CHF due to its lack of cardioselectivity. It has not been shown to decrease mortality in patients with CHF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Labetalol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Labetalol is a non-selective beta-blocker with additional alpha-blocking properties. While it is useful in the management of hypertensive emergencies, it is not used for chronic management of CHF and has not been shown to decrease mortality in these patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pindolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pindolol is another non-selective beta-blocker with intrinsic sympathomimetic activity (ISA). It is not suitable for CHF management and does not have evidence supporting a mortality benefit in heart failure patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisoprolol is a cardioselective beta-blocker that has been shown to decrease mortality in patients with chronic congestive heart failure.</span></span></span></p>",
    "correct_choice_id": 228518,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 76162,
    "choices": [
      {
        "id": 303521,
        "text": "<p><span style=\"font-size:16px;\">Ministry of Health and Family Welfare</span></p>"
      },
      {
        "id": 303522,
        "text": "<p><span style=\"font-size:16px;\">Ministry of Home Affairs</span></p>"
      },
      {
        "id": 303523,
        "text": "<p><span style=\"font-size:16px;\">Ministry of Environment, Forests and Climate Change</span></p>"
      },
      {
        "id": 303524,
        "text": "<p><span style=\"font-size:16px;\">Ministry of Social Justice and Empowerment</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which is the Nodal Ministry for Disaster Management? (FMGE JAN 2025)</span></p>",
    "unique_key": "Q8794585",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947627,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) Ministry of Home Affairs</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The Ministry of Home Affairs is the nodal ministry for disaster management in India. The National Disaster Management Authority (NDMA) functions under the Ministry of Home Affairs, with the Prime Minister serving as its chairperson. The nodal center for disaster management is at the district level.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option A. Ministry of Health and Family Welfare:</strong> While this ministry plays a role in health-related aspects of disasters, it is not the nodal ministry for overall disaster management.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Ministry of Environment, Forests and Climate Change:</strong> This ministry deals with environmental aspects but is not responsible for coordinating disaster management activities.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Ministry of Social Justice and Empowerment:</strong> This ministry focuses on social welfare programs but does not coordinate disaster management activities.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The Ministry of Home Affairs serves as the nodal ministry for disaster management in India, with the district being the nodal center for implementation. NDMA functions under the Ministry of Home Affairs with the Prime Minister as its chairperson.</span></p>",
    "correct_choice_id": 303522,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 80902,
    "choices": [
      {
        "id": 322292,
        "text": "<p><span style=\"font-size:12.0pt;\">Autism</span></p>"
      },
      {
        "id": 322293,
        "text": "<p><span style=\"font-size:12.0pt;\">ADHD</span></p>"
      },
      {
        "id": 322294,
        "text": "<p><span style=\"font-size:12.0pt;\">Mental Retardation</span></p>"
      },
      {
        "id": 322295,
        "text": "<p><span style=\"font-size:12.0pt;\">Specific Learning Disability</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A two-year-old boy presents with delayed speech, difficulties in communication, and repetitive behaviors such as staring at his own hands. He struggles with making friends and concentrating. What is the most likely diagnosis?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
    "unique_key": "Q2626716",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947629,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Autism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation strongly suggests Autism (now classified as Autism Spectrum Disorder in current diagnostic systems). The key features presented in this case include:</span></p><ol><li><span style=\"font-size:12.0pt;\">Delayed speech and difficulties in communication (language impairment)</span></li><li><span style=\"font-size:12.0pt;\">Repetitive behaviors (staring at hands) which represent restricted, repetitive patterns of behavior</span></li><li><span style=\"font-size:12.0pt;\">Social interaction difficulties (struggles with making friends)</span></li><li><span style=\"font-size:12.0pt;\">Age of presentation before 3 years (the child is 2 years old)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These symptoms align perfectly with the core diagnostic criteria of autism, which includes impairments in social interaction, and restricted/repetitive behaviors. Communication deficits are also often seen in autism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option B. ADHD (Incorrect)</strong>: While ADHD can present with concentration difficulties, it typically doesn't include speech delays, repetitive behaviors, or social interaction difficulties as primary symptoms. ADHD is characterized primarily by inattention, hyperactivity, and impulsivity.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Mental Retardation (Incorrect)</strong>: Now termed <strong>Intellectual Disability,</strong> this condition involves below-average intellectual functioning and adaptive behavior. While intellectual disability can co-occur with autism (around 30% of cases), the repetitive behaviors and specific social interaction difficulties described are more characteristic of autism than isolated intellectual disability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Specific Learning Disability (Incorrect)</strong>: Learning disabilities involve difficulties in specific academic skills (reading, writing, mathematics) out of proportion to the intellectual functioning of the child. They aren't typically diagnosed in toddlers as these skills aren't yet expected, and they don't explain the communication deficits, repetitive behaviors, or social difficulties described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Autism is characterized by impairments in social interaction, and restricted/repetitive behaviors. Communication deficits are also often present in autism. These symptoms typically manifest before age 3, making early identification possible.&nbsp;</span></p>",
    "correct_choice_id": 322292,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44897,
    "choices": [
      {
        "id": 179235,
        "text": "<p><span style=\"font-size:12.0pt;\">Max Joseph Cleft</span></p>"
      },
      {
        "id": 179236,
        "text": "<p><span style=\"font-size:12.0pt;\">Civatte bodies</span></p>"
      },
      {
        "id": 179237,
        "text": "<p><span style=\"font-size:12.0pt;\">Sawtooth profile of rete ridges</span></p>"
      },
      {
        "id": 179238,
        "text": "<p><span style=\"font-size:12.0pt;\">Munro microabscess</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a classical histological feature of Lichen Planus? (NEET PG 2017)</span></p>",
    "unique_key": "Q9281018",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947640,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Munro microabscess.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is not a feature of lichen planus.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Munro microabscesses</strong> are collections of <strong>neutrophils in the stratum corneum</strong>, and are a hallmark of <strong>psoriasis</strong>, not lichen planus.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:323/196;width:69.07%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/103.png\" width=\"323\" height=\"196\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Their presence helps differentiate psoriasis from lichenoid dermatoses histologically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Max Joseph Cleft:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Max Joseph space is an artifactual cleft that forms at the<strong> dermo-epidermal junction</strong> due to the extensive <strong>basal cell damage</strong> in lichen planus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Civatte bodies:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Civatte bodies</strong> (also called <strong>colloid&nbsp;</strong>bodies) are<strong> apoptotic keratinocytes</strong> that appear as eosinophilic, rounded structures in the lower epidermis and <strong>papillary dermis</strong> of lichen planus lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sawtooth profile of rete ridges:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The <strong>sawtooth appearance</strong> of the rete ridges is characteristic of lichen planus and results from the <strong>irregular acanthosis</strong> combined with <strong>basal cell damage.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/22.jpg\" width=\"1200\" height=\"672\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture36.png\" width=\"531\" height=\"310\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-03%20135324.png\" width=\"1002\" height=\"712\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Munro microabscesses</strong> are a classical histological feature of <strong>psoriasis</strong>, not <strong>lichen planus,&nbsp;</strong>which is characterized by <strong>Max Joseph clefts, Civatte bodies, and sawtooth rete ridges.</strong></span></li></ul>",
    "correct_choice_id": 179238,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44829,
    "choices": [
      {
        "id": 178963,
        "text": "<p><span style=\"font-size:12pt;\">Evolocumab</span></p>"
      },
      {
        "id": 178964,
        "text": "<p><span style=\"font-size:12pt;\">Ezetimibe</span></p>"
      },
      {
        "id": 178965,
        "text": "<p><span style=\"font-size:12pt;\">Evinacumab</span></p>"
      },
      {
        "id": 178966,
        "text": "<p><span style=\"font-size:12pt;\">Everolimus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is a PCSK-9 inhibtior? (</span>INICET May 2024)</p>",
    "unique_key": "Q4341520",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947631,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Evolocumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK-9). By inhibiting PCSK-9, evolocumab increases the number of low-density lipoprotein (LDL) receptors available on the surface of liver cells, thereby reducing LDL cholesterol levels in the blood. It is used for the treatment of hypercholesterolemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ezetimibe</strong>:&nbsp;Ezetimibe is a cholesterol absorption inhibitor that works by reducing the absorption of cholesterol in the small intestine. It is used to lower LDL cholesterol levels but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Evinacumab</strong>:&nbsp;Evinacumab is a monoclonal antibody that inhibits angiopoietin-like protein 3 (ANGPTL3), which reduces levels of triglycerides, LDL cholesterol, and other lipids. It is used for treating homozygous familial hypercholesterolemia but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Everolimus</strong>:&nbsp;Everolimus is an mTOR inhibitor used primarily as an immunosuppressant in transplant patients and in certain types of cancer. It is not related to cholesterol metabolism and is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, evolocumab is the correct answer as it is a PCSK-9 inhibitor used to lower LDL cholesterol levels.</span></p>",
    "correct_choice_id": 178963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20909,
    "choices": [
      {
        "id": 83600,
        "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
      },
      {
        "id": 83601,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
      },
      {
        "id": 83602,
        "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone</span></p>"
      },
      {
        "id": 83603,
        "text": "<p><span style=\"font-size:12.0pt;\">Methyl ergometrine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A pregnant woman with a history of bronchial asthma in third stage of labor. Which of the following drugs should be avoided in the management of postpartum hemorrhage in this patient? (NEET PG 2023)</span></p>",
    "unique_key": "Q7116298",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947634,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Carboprost</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The drug that should be avoided in this patient with a history of bronchial asthma is carboprost since it can cause bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><u>Carboprost (PGF2\u03b1 analogue)</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Action - It increases uterine tone by contracting upper segment of uterus</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Use - To control postpartum hemorrhage (DOC \u2013 Oxytocin).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A/E - Vomiting, diarrhea, and bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Contraindications -</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-164227.png\" alt=\"\" width=\"1000\" height=\"220\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Oxytocin</strong></span><span style=\"font-size:12pt;\">: Oxytocin is the first-line drug to prevent and treat PPH and also used in augmentation of labour according to WHO guidelines. Administered by intravenous route and may lead to hypotension and reflex tachycardia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Dinoprostone</strong>: Dinoprostone is a PGE2 analogue used for cervical ripening, induction of labor, and in atony treatment. It should be avoided in patients with a history of asthma, glaucoma, or myocardial infarction. One major adverse effect is uterine hyperstimulation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Methyl ergometrine:</strong> Ergot derivatives are used in the control of postpartum uterine bleeding. It is given intramuscularly and is effective within 1-5 minutes. It is given at the time of delivery of the placenta or immediately after if bleeding is significant. Side effects are gastrointestinal disturbances like diarrhea, nausea, and vomiting.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Carboprost should be avoided in the management of postpartum hemorrhage in patients with a history of bronchial asthma due to its potential to cause bronchoconstriction.</span></p>",
    "correct_choice_id": 83600,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6522,
    "choices": [
      {
        "id": 26057,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin</span></span></span></p>"
      },
      {
        "id": 26058,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">\ufeff\ufeff\ufeffHeparin</span></span></span></p>"
      },
      {
        "id": 26059,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">\ufeff\ufeff\ufeffDabigatran</span></span></span></p>"
      },
      {
        "id": 26060,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">\ufeff\ufeff\ufeffRivaroxaban</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with deep vein thrombosis was started on a new drug. After 2 days, he presented with the given finding. Which of the following drugs is implicated in causing the below condition?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2022)</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/04/2.jpg\" style=\"height:198px; width:200px\" /></span></span></p>",
    "unique_key": "Q5920531",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947643,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Warfarin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The figure shows clinical picture of dermal vascular necrosis, also known as &lsquo;purple toe syndrome&rsquo;. It is an early adverse effect of warfarin. It is seen in patients with genetic protein C deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermal Vascular Necrosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin-induced dermal vascular necrosis is a rare complication of warfarin therapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It characterized by the development of painful skin lesions in patients taking warfarin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is thought to be caused by a transient hypercoagulable state resulting from a rapid reduction in protein C levels in patients with underlying protein C deficiency or other risk factors. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesions typically occur in areas with a high concentration of adipose tissue, such as the breasts, thighs, and buttocks.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial symptoms include red or purple spots on the skin that can quickly progress to painful, necrotic lesions with a central blister or eschar. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The diagnosis is usually made clinically based on the characteristic appearance of the lesions and the patient&#39;s history of warfarin therapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of dermal vascular necrosis involves stopping warfarin and initiating alternative anticoagulant therapy, such as heparin or low molecular weight heparin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In severe cases, surgical intervention may be necessary to remove the necrotic tissue and prevent further damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Heparin:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heparin is an anticoagulant that works by activating antithrombin III, which in turn inhibits thrombin and factor Xa. It does not cause dermal vascular necrosis. However, heparin can cause other complications such as heparin-induced thrombocytopenia (HIT).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dabigatran:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dabigatran is a direct thrombin inhibitor used as an anticoagulant. It does not cause dermal vascular necrosis and is generally associated with a different profile of side effects, including bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rivaroxaban:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rivaroxaban is a direct factor Xa inhibitor used for anticoagulation. It does not cause dermal vascular necrosis and is associated with a different side effect profile, mainly related to bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin can cause dermal vascular necrosis, particularly in patients with protein C deficiency, presenting as painful, necrotic skin lesions shortly after initiation of therapy.</span></span></span></p>",
    "correct_choice_id": 26057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44553,
    "choices": [
      {
        "id": 177859,
        "text": "<p><span style=\"font-size:12.0pt;\">Alopecia Areata</span></p>"
      },
      {
        "id": 177860,
        "text": "<p><span style=\"font-size:12.0pt;\">Secondary syphilis</span></p>"
      },
      {
        "id": 177861,
        "text": "<p><span style=\"font-size:12.0pt;\">Black dot type Tinea Capitis</span></p>"
      },
      {
        "id": 177862,
        "text": "<p><span style=\"font-size:12.0pt;\">Discoid Lupus Erythematosus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not considered a focal non-cicatricial cause of alopecia? (NEET PG 2017)</span></p>",
    "unique_key": "Q1779858",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947630,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Discoid Lupus Erythematosus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Discoid Lupus Erythematosus (DLE) is a <strong>cicatricial (scarring) form of alopecia</strong>, not a non-cicatricial cause.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture33.png\" width=\"316\" height=\"400\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">DLE destroys hair follicles, leading to <strong>permanent hair loss&nbsp;</strong>with scarring.&nbsp;</span></li><li><span style=\"font-size:16px;\">It's specifically classified under <strong>\"Connective tissue diseases\"</strong> in scarring alopecias.&nbsp;</span></li><li><span style=\"font-size:16px;\">When DLE affects the scalp, it leads to <strong>inflammatory lesions</strong> that heal with scarring, resulting in irreversible hair loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Alopecia Areata:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is correctly classified as a <strong>non-cicatricial alopecia.&nbsp;</strong></span></li><li><span style=\"font-size:16px;\">It's characterized by circular patches of <strong>complete hair loss</strong> with <strong>exclamation mark hairs&nbsp;</strong>at the periphery.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img class=\"image_resized\" style=\"aspect-ratio:336/360;width:60.84%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/101_rUBwAdr.png\" width=\"336\" height=\"360\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Hair follicles remain <strong>preserved</strong>, making it potentially <strong>reversible.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Secondary Syphilis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Secondary syphilis can cause a <strong>moth-eaten</strong>, patchy pattern of hair loss, which is <strong>non-cicatricial</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/102.png\" width=\"348\" height=\"217\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Black Dot Type Tinea Capitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is a <strong>non-inflammatory</strong> type of tinea capitis where infected hairs break off at the scalp surface, leaving behind characteristic black dots.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture34_flCKJZ5.png\" width=\"364\" height=\"498\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">It is <strong>non-cicatricial,</strong> as there is no permanent follicular damage.&nbsp;</span></li><li><span style=\"font-size:16px;\">However, <strong>other inflammatory forms of tinea capitis</strong> like <strong>kerion</strong> (boggy inflammatory mass) and<strong> favu</strong>s (yellow cup-shaped crusts) can destroy hair follicles and cause <strong>cicatricial alopecia</strong> if not treated early.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Discoid Lupus Erythematosus (DLE)&nbsp;</strong>is a cause of <strong>focal cicatricial alopecia</strong> and thus is not classified among focal non-cicatricial causes of hair loss.</span></li></ul>",
    "correct_choice_id": 177862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55634,
    "choices": [
      {
        "id": 221981,
        "text": "<p><span style=\"font-size:12.0pt;\">Radial nerve</span></p>"
      },
      {
        "id": 221982,
        "text": "<p><span style=\"font-size:12.0pt;\">Ulnar nerve</span></p>"
      },
      {
        "id": 221983,
        "text": "<p><span style=\"font-size:12.0pt;\">Musculocutaneous nerve</span></p>"
      },
      {
        "id": 221984,
        "text": "<p><span style=\"font-size:12.0pt;\">Median nerve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A victim of road traffic accident (RTA) presents with fracture of hand with hypothenar atrophy. Nerve involved in him is: (FMGE JULY 2024)</span></p>",
    "unique_key": "Q2616290",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947626,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ulnar&nbsp;nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In the hand, the ulnar nerve gives motor innervation to the hypothenar (palmaris brevis, abductor digiti minimi, flexor digiti minimi, opponens digiti minimi) and the thenar (adductor pollicis, deep head of flexor pollicis brevis) muscles.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Also, it supplies the palmar and dorsal interossei and medial 2 lumbricals.</span></li><li><span style=\"background-color:white;color:black;font-size:12.0pt;\">The ulnar nerve is most susceptible to injury at the elbow&nbsp;and the wrist, resulting in motor and sensory loss.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Mechanisms of injury include trauma like motor vehicle accident; nerve impingement; lacerations at the wrist; and Guyon\u2019s canal cyst.</span></li><li><span style=\"font-size:12.0pt;\">A motor vehicle accident resulting in a fracture of the metacarpal or phalanges can lead to injury of the ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">This is indicated by the atrophy of the hypothenar muscles, leading to flattening of the hypothenar eminence.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Other&nbsp;clinical features of ulnar nerve injury include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">Loss of hypothenar eminence</span></li><li><span style=\"color:black;font-size:12.0pt;\">Loss of adduction of thumb</span></li><li><span style=\"color:black;font-size:12.0pt;\">Loss of abduction of fingers</span></li><li><span style=\"color:black;font-size:12.0pt;\">Clawing of 4th and 5th digits</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Radial&nbsp;nerve:</strong> The radial nerve supplies the extensor muscles of the forearm and hand. Injury to this nerve would typically result in wrist drop due to loss of extensor muscle function, not hypothenar atrophy.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Musculocutaneous&nbsp;nerve:</strong> The musculocutaneous nerve supplies the biceps, brachialis, and coracobrachialis muscles in the upper arm. Its involvement would affect arm flexion and not the hypothenar muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Median&nbsp;nerve:</strong> The median nerve supplies the thenar eminence and the first two lumbricals. Injury to this nerve would result in issues with thumb opposition and grip, but not hypothenar atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Flexor pollicis brevis superficial head is supplied by median nerve and deep head is supplied by ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">The first and second lumbricals are supplied by the median nerve.</span></li><li><span style=\"font-size:12.0pt;\">The third and fourth lumbricals are supplied by the ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">When the lumbricals are paralyzed, they can result in a deformity known as a <strong>\"claw hand.\"</strong></span></li><li><span style=\"font-size:12.0pt;\">Ulnar or median nerve injury can lead to a deformity known as \"claw hand.\"</span></li><li><span style=\"font-size:12.0pt;\">Among these, ulnar nerve palsy is more commonly associated with claw hand.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hypothenar atrophy is a clinical sign of ulnar nerve injury.</span></li></ul>",
    "correct_choice_id": 221982,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 57285,
    "choices": [
      {
        "id": 228521,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></p>"
      },
      {
        "id": 228522,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rivastigmine</span></span></p>"
      },
      {
        "id": 228523,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex</span></span></p>"
      },
      {
        "id": 228524,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinylcholine</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with mild to moderate renal failure requires reversal of muscle relaxation induced by vecuronium. Which of the following drugs is appropriate for this purpose? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q4861888",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947635,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Sugammadex</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vecuronium is a non-depolarizing muscle relaxant used during surgeries to facilitate intubation and muscle relaxation. After the procedure, it is often necessary to reverse the effects of vecuronium to allow the patient to regain muscle function. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is a selective relaxant binding agent (SRBA) specifically designed to reverse the effects of certain non-depolarizing muscle relaxants, including vecuronium and rocuronium. It works by encapsulating the vecuronium molecules, effectively reducing their availability to bind to nicotinic receptors at the neuromuscular junction, thereby reversing muscle paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is preferred in patients with mild to moderate renal failure because it is highly effective and works faster than traditional agents like neostigmine. While Sugammadex is contraindicated in severe or end-stage renal disease due to reduced clearance, it can be safely used in mild to moderate renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversal agents for muscle relaxants used in anesthesia include neostigmine and Sugammadex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cholinergic drug that inhibits acetylcholinesterase, leading to increased acetylcholine.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes cholinergic side effects due to the increased acetylcholine.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used for all muscle relaxants.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be given in renal disease patients </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If neostigmine is not an option and the patient has mild to moderate renal failure, Sugammadex is the preferred choice.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Physostigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Physostigmine is an acetylcholinesterase inhibitor, but it is primarily used to reverse the effects of central nervous system depressants and is not typically used for reversing non-depolarizing muscle relaxants like vecuronium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rivastigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rivastigmine is also an acetylcholinesterase inhibitor, but it is used in the management of Alzheimer&#39;s disease and other types of dementia, not for reversing muscle relaxants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Succinylcholine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Succinylcholine is a depolarizing muscle relaxant used for short-term muscle relaxation, such as during intubation. It is not used for reversing the effects of non-depolarizing muscle relaxants like vecuronium and, in fact, would induce more muscle relaxation rather than reverse it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sugammadex is the appropriate agent for reversing the effects of vecuronium in patients with mild to moderate renal failure due to its specific action on non-depolarizing muscle relaxants and its faster onset of action.</span></span></span></p>",
    "correct_choice_id": 228523,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 80901,
    "choices": [
      {
        "id": 322288,
        "text": "<p><span style=\"font-size:12.0pt;\">Schizophrenia</span></p>"
      },
      {
        "id": 322289,
        "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
      },
      {
        "id": 322290,
        "text": "<p><span style=\"font-size:12.0pt;\">Dementia</span></p>"
      },
      {
        "id": 322291,
        "text": "<p><span style=\"font-size:12.0pt;\">Conversion Disorder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Delusions are commonly observed in all of the following conditions, except:</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
    "unique_key": "Q5403346",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947619,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Conversion Disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conversion Disorder (also called Functional Neurological Symptom Disorder or Dissociative Neurological Symptom Disorder in ICD-11) is characterized by neurological symptoms like paralysis, blindness, or seizures that cannot be explained by medical conditions. Importantly, delusions are not a feature of conversion disorder. Conversion disorder involves a psychological stressor that manifests as physical symptoms, but the patient does not have false, fixed beliefs (delusions) about their condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Schizophrenia (Incorrect)</strong>: Delusions are core symptoms of schizophrenia. According to the DSM-5 criteria, delusions are one of the characteristic positive symptoms required for diagnosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Depression (Incorrect)</strong>: Delusions can develop in a patient with depression. These may include delusions of guilt, nihilistic delusions (e.g., believing internal organs have rotted), or delusions of poverty.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Dementia (Incorrect)</strong>: Delusions can occur in dementia, particularly in moderate to severe stages. These are usually transient and less complex than those seen in primary psychotic disorders. Common delusions in dementia include persecutory delusions, delusions of theft, or misidentification delusions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delusions are common features of psychotic disorders like schizophrenia, severe mood disorders with psychotic features (including depression), and neurocognitive disorders like dementia. Conversion disorder, however, is characterized by unexplained neurological symptoms without the presence of delusions, as it belongs to the somatic symptom/dissociative disorder category rather than the psychotic spectrum.</span></p>",
    "correct_choice_id": 322291,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44786,
    "choices": [
      {
        "id": 178791,
        "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
      },
      {
        "id": 178792,
        "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
      },
      {
        "id": 178793,
        "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
      },
      {
        "id": 178794,
        "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
    "unique_key": "Q4462466",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947621,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient\u2019s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
    "correct_choice_id": 178791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6505,
    "choices": [
      {
        "id": 25989,
        "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
      },
      {
        "id": 25990,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blockers</span></p>"
      },
      {
        "id": 25991,
        "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin-converting enzyme inhibitors</span></p>"
      },
      {
        "id": 25992,
        "text": "<p><span style=\"font-size:12.0pt;\">Alpha methyldopa</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old chronic hypertensive woman visits the outpatient department for pre-conceptional counseling. Which of the following anti-hypertensive should she discontinue? (NEET PG 2021)</span></p>",
    "unique_key": "Q2018825",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947632,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Angiotensin-converting enzyme inhibitors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These medications are contraindicated during pregnancy because they are associated with fetal renal dysplasia, oligohydramnios, and other congenital anomalies. Therefore, women who are planning to conceive should discontinue these medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Labetalol</strong>: Labetalol is generally safe for use during pregnancy and is a treatment option for hypertension in pregnant women. It is not necessary to discontinue this medication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium channel blockers</strong>: Calcium channel blockers like nifedipine are also generally considered safe during pregnancy and are often used to manage hypertension in pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alpha methyldopa</strong>: Alpha methyldopa is also considered safe during pregnancy and is commonly used for managing hypertension in this population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the woman's intention to conceive, discontinuing Angiotensin-converting enzyme inhibitors would be the most appropriate course of action to protect both her health and that of her future child.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ACE inhibitors should be discontinued in women who are planning to conceive due to their associated risks of fetal renal dysplasia, oligohydramnios, and other congenital anomalies. Alternative antihypertensive medications that are safer during pregnancy include labetalol, calcium channel blockers, and alpha methyldopa.</span></p>",
    "correct_choice_id": 25991,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20908,
    "choices": [
      {
        "id": 83596,
        "text": "<p><span style=\"font-size:12.0pt;\">Clotrimazole</span></p>"
      },
      {
        "id": 83597,
        "text": "<p><span style=\"font-size:12.0pt;\">Griseofulvin</span></p>"
      },
      {
        "id": 83598,
        "text": "<p><span style=\"font-size:12.0pt;\">Terbinafine</span></p>"
      },
      {
        "id": 83599,
        "text": "<p><span style=\"font-size:12.0pt;\">Flucytosine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A bronchial asthma patient who is on inhalational steroids presented with white patchy lesions on the tongue and buccal mucosa. What is the drug that can be used to treat this condition?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
    "unique_key": "Q5226795",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947624,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Clotrimazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of white patchy lesions on the tongue and buccal mucosa in a patient using inhalational steroids points to diagnosis of oral candidiasis and drug that can be used for the treatment is clotrimazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Asthma patients use MDI which can result in deposition of steroids in the oropharyngeal space, which might lead to cough, dysphonia, and oral candidiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is classified under Azole group of Anti-Fungal drugs, acts by inhibiting fungal sterol (ergosterol) synthesis. Used topically in treatment for topical fungal infections like tinea and candida</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture1.jpg\" alt=\"\" width=\"700\" height=\"289\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Griseofulvin</strong>: Griseofulvin interferes with microtubule function and disrupts mitosis, disrupting the fungal cell division. It is mainly used against dermatophytes and is the drug of choice for tinea capitis in children. But it is not effective against Candida.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Terbinafine</strong>: Terbinafine acts by inhibiting the fungal enzyme squalene epoxidase. which reduces ergosterol biosynthesis. Used to treat nail onychomycosis and other dermatophytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Flucytosine</strong></span><span style=\"font-size:12pt;\">: Flucytosine acts by inhibiting nucleic acid synthesis. Used exclusively to combat systemic fungal infections (e.g., cryptococcal meningitis) in combination with amphotericin B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is the drug of choice for treating oral candidiasis, especially in patients who develop the condition as a side effect of inhalational steroid use. It works by inhibiting ergosterol synthesis, compromising the fungal cell membrane integrity.</span></p>",
    "correct_choice_id": 83596,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 80896,
    "choices": [
      {
        "id": 322268,
        "text": "<p><span style=\"font-size:12.0pt;\">Late onset</span></p>"
      },
      {
        "id": 322269,
        "text": "<p><span style=\"font-size:12.0pt;\">Presence of Depression</span></p>"
      },
      {
        "id": 322270,
        "text": "<p><span style=\"font-size:12.0pt;\">Predominant Negative Symptoms</span></p>"
      },
      {
        "id": 322271,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute onset</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are associated with good prognosis in schizophrenia, except:</span><span style=\"font-size:16px;\"> (NEET PG 2015)</span></p>",
    "unique_key": "Q6386925",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947628,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Predominant Negative symptoms</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong> Predominant negative symptoms are associated with poor prognosis in schizophrenia, not good prognosis. Negative symptoms (often remembered as the \"6As\") include avolition (loss of drive), apathy (lack of concern), anhedonia (loss of pleasure), asociality (lack of social interaction), affective flattening (lack of emotional response), and alogia (decreased verbal communication). These symptoms respond poorly to medications and are considered poor prognostic factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Late onset (Incorrect)</strong>: Advanced age of onset (&gt;35 years) is associated with better prognosis in schizophrenia. Early onset (&lt;20 years) is linked to poorer outcomes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Presence of Depression (Incorrect)</strong>: The presence of affective symptoms, including depression, is associated with better prognosis in schizophrenia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Acute onset (Incorrect)</strong>: Acute or abrupt onset of symptoms is associated with better prognosis compared to insidious onset.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Good prognostic factors in schizophrenia include acute/abrupt onset, later age of onset (&gt;35 years), female gender, presence of affective symptoms, and predominant positive symptoms. Poor prognostic factors include insidious onset, early onset (&lt;20 years), male gender, predominant negative symptoms, and absence of affective symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-15%20154654.png\" width=\"1025\" height=\"504\"></span></p>",
    "correct_choice_id": 322270,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44866,
    "choices": [
      {
        "id": 179111,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Mifepristone</span></p>"
      },
      {
        "id": 179112,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Cabergoline</span></p>"
      },
      {
        "id": 179113,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Chlorpromazine</span></p>"
      },
      {
        "id": 179114,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Metoclopramide</span></p>"
      }
    ],
    "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old woman has experienced the loss of her newborn. She is currently producing breast milk, leading to discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. Which of the following drug can be used to prevent this complication? (</span>INICET May 2024)</p>",
    "unique_key": "Q3699515",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947641,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the goal is to prevent lactation to avoid discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. The appropriate treatment involves using a drug that can suppress prolactin secretion, as prolactin is the hormone responsible for stimulating milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cabergoline is a dopamine agonist that inhibits prolactin secretion, effectively suppressing lactation. It is often used for this purpose and can be an effective choice in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Mifepristone</strong>: Mifepristone is an antiprogestin used for medical termination of pregnancy. It does not have a direct role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Chlorpromazine</strong>: Chlorpromazine is an antipsychotic medication that can increase prolactin levels, which would not be helpful in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metoclopramide</strong>: Metoclopramide is a prokinetic agent and antiemetic that also increases prolactin levels, making it unsuitable for suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given these options, the correct choice for preventing lactation and thus avoiding the associated complications is:&nbsp;<strong>b. Cabergoline</strong></span></p>",
    "correct_choice_id": 179112,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 76163,
    "choices": [
      {
        "id": 303525,
        "text": "<p><span style=\"font-size:16px;\">NLEP, leprosy has a vaccine available</span></p>"
      },
      {
        "id": 303526,
        "text": "<p><span style=\"font-size:16px;\">NLEP, Leprosy has been eliminated</span></p>"
      },
      {
        "id": 303527,
        "text": "<p><span style=\"font-size:16px;\">NLEP, Leprosy is curable, reduce stigma, spread awareness</span></p>"
      },
      {
        "id": 303528,
        "text": "<p><span style=\"font-size:16px;\">NLEP, leprosy can\u2019t affect children</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">The image of the mascot \u2018Sapna\u2019 shown below and identify what does she represent in the national health program: (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ehn5Gf2.png\" width=\"197\" height=\"315\"></span></p>",
    "unique_key": "Q5899432",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947637,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) NLEP, Leprosy is curable, reduce stigma, spread awareness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>'Sapna'</strong> is the mascot of <strong>National Leprosy Eradication Program (NLEP)</strong> in India. She represents the success story of leprosy treatment, as she herself was a leprosy patient who got completely cured after taking multi-drug therapy (MDT). Her role is to spread awareness about:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Curability of leprosy through MDT</span></li><li><span style=\"font-size:16px;\">Reducing stigma and discrimination associated with leprosy in society</span></li><li><span style=\"font-size:16px;\">Encouraging early detection and treatment seeking behavior</span></li><li><span style=\"font-size:16px;\">Demonstrating that leprosy patients can lead a normal life after treatment</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. NLEP, leprosy has a vaccine available:&nbsp;</strong>Incorrect because there is no widely accepted vaccine for leprosy currently available for public use</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. NLEP, Leprosy has been eliminated:&nbsp;</strong>While India achieved elimination status (&lt;1 case/10,000 population) in December 2005, the program continues as new cases still occur</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. NLEP, leprosy can't affect children:&nbsp;</strong>Incorrect as leprosy can affect people of any age group including children</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sapna is the mascot of NLEP who represents successful treatment of leprosy and aims to reduce stigma while spreading awareness about curability of the disease through multi-drug therapy.</span></p>",
    "correct_choice_id": 303527,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 80897,
    "choices": [
      {
        "id": 322272,
        "text": "<p><span style=\"font-size:12.0pt;\">Insidious onset</span></p>"
      },
      {
        "id": 322273,
        "text": "<p><span style=\"font-size:12.0pt;\">Often irreversible</span></p>"
      },
      {
        "id": 322274,
        "text": "<p><span style=\"font-size:12.0pt;\">Clouding of consciousness</span></p>"
      },
      {
        "id": 322275,
        "text": "<p><span style=\"font-size:12.0pt;\">Impaired remote memory</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true about dementia and differentiate it from delirium, except:</span><span style=\"font-size:16px;\"> (NEET PG 2015)</span></p>",
    "unique_key": "Q4085047",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947638,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Clouding of consciousness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clouding of consciousness is a characteristic feature of delirium, not dementia. The disturbance of consciousness is considered one of the hallmark symptoms of delirium and represents a key distinguishing feature between these two neurocognitive disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Insidious onset (Incorrect)</strong>: Dementia typically has an insidious onset with gradual progression, while delirium has a sudden onset. This is a true differentiating feature of dementia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Often irreversible (Incorrect)</strong>: Most dementias are irreversible and progressive conditions, unlike delirium which is usually reversible if the underlying cause is identified and treated. This is a true differentiating feature of dementia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Impaired remote memory (Incorrect)</strong>: In dementia, memory impairment follows a pattern where recent memory is affected first, followed by immediate memory, and finally remote memory in later stages. In delirium, immediate and recent memory are primarily affected while remote memory remains relatively intact. Impaired remote memory in later stages is a feature of dementia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The key differences between dementia and delirium include: dementia has insidious onset and progressive course while delirium has sudden onset and fluctuating course; consciousness is preserved in dementia but disturbed in delirium; and dementia is often irreversible whereas delirium is usually reversible when the underlying cause is treated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-15%20154903.png\" width=\"1442\" height=\"387\"></span></p>",
    "correct_choice_id": 322274,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6521,
    "choices": [
      {
        "id": 26053,
        "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
      },
      {
        "id": 26054,
        "text": "<p><span style=\"font-size:12.0pt;\">Methysergide</span></p>"
      },
      {
        "id": 26055,
        "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
      },
      {
        "id": 26056,
        "text": "<p><span style=\"font-size:12.0pt;\">Nitrofurantoin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is not likely to cause a pleural pathology? (NEET PG 2022)</span></p>",
    "unique_key": "Q9157054",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947633,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metformin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is an oral hypoglycemic agent used primarily in the treatment of type 2 diabetes mellitus. It works by decreasing hepatic glucose production and increasing insulin sensitivity. Metformin is not associated with pleural pathologies, making it the correct choice in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methysergide</strong>: Methysergide is a medication used to prevent migraine headaches and is known for its potential to cause retroperitoneal and pleural fibrosis. This pleural pathology is a serious adverse effect, although the drug is not commonly used today due to this risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bleomycin</strong>: Bleomycin is a chemotherapeutic agent used in the treatment of various cancers. One of its well-known side effects is pulmonary toxicity, which can manifest as pulmonary fibrosis. Pleural involvement, including pleural effusions and fibrosis, can occur secondary to its pulmonary effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nitrofurantoin</strong>: Nitrofurantoin is an antibiotic used primarily for urinary tract infections. It can cause pulmonary reactions, including acute, subacute, and chronic pulmonary reactions. These reactions can involve the pleura, leading to pleural effusions and other pleural pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is not associated with causing pleural pathologies, unlike Methysergide, Bleomycin, and Nitrofurantoin, which have known risks of causing pleural and pulmonary complications.</span></p>",
    "correct_choice_id": 26053,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6520,
    "choices": [
      {
        "id": 26049,
        "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-10</span></p>"
      },
      {
        "id": 26050,
        "text": "<p><span style=\"font-size:12.0pt;\">Histone deacetylase</span></p>"
      },
      {
        "id": 26051,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine A1</span></p>"
      },
      {
        "id": 26052,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta 2 adrenergic receptors</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Theophylline was prescribed to a male patient with chronic obstructive pulmonary disease (COPD). The next day, he noticed that his urine output had increased. Which of the following receptors is responsible for the drug's action?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
    "unique_key": "Q5381441",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947623,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine A1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline is a methylxanthine drug that primarily acts as a nonselective adenosine receptor antagonist. By antagonizing adenosine A1 receptors, theophylline can lead to diuresis or increased urine output. Adenosine normally promotes water reabsorption in the renal tubules, and its blockade by theophylline results in increased urine production. This mechanism is separate from its therapeutic action in COPD, which involves bronchodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Interleukin-10</strong>: Interleukin-10 (IL-10) is an anti-inflammatory cytokine. It is not a direct target of theophylline. IL-10 plays a role in regulating immune responses, but it is not involved in the diuretic effect or the primary action of theophylline in COPD treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Histone Deacetylase</strong>: Histone deacetylase (HDAC) is an enzyme involved in chromatin remodelling and gene expression regulation. While theophylline has been suggested to have some modulatory effects on HDAC, especially in the context of COPD and asthma, it is not the mechanism responsible for the increased urine output observed in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Beta 2 Adrenergic Receptors</strong>: While theophylline has mild bronchodilatory effects thought to be mediated through inhibition of phosphodiesterase (increasing cAMP levels in smooth muscle), leading to relaxation of bronchial smooth muscles, beta 2 adrenergic receptors are more specifically targeted by drugs like salbutamol. Theophylline's diuretic effect is not mediated through beta 2 adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline increases urine output by antagonizing adenosine A1 receptors, leading to decreased water reabsorption in the renal tubules and resulting in diuresis.</span></p>",
    "correct_choice_id": 26051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 79534,
    "choices": [
      {
        "id": 316871,
        "text": "<p><span style=\"font-size:12.0pt;\">Macule</span></p>"
      },
      {
        "id": 316872,
        "text": "<p><span style=\"font-size:12.0pt;\">Papule</span></p>"
      },
      {
        "id": 316873,
        "text": "<p><span style=\"font-size:12.0pt;\">Patch</span></p>"
      },
      {
        "id": 316874,
        "text": "<p><span style=\"font-size:12.0pt;\">Vesicle</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the term for a primary skin lesion that is flat, without elevation or depression, and less than 1 cm in diameter? (NEET PG 2017)</span></p>",
    "unique_key": "Q5765731",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947620,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Macule</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A macule is a circumscribed, flat lesion of skin that is visible because of a <strong>change in skin color.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/14_rcWdXBN.jpg\" width=\"1200\" height=\"683\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It is<strong> neither elevated nor depressed</strong>, has no change in skin texture, and by definition is <strong>less than 1 cm in diameter.&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">Macules can be<strong> hyperpigmented</strong> (like fixed drug eruption), <strong>hypopigmented</strong> (like leprosy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papule&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A papule is a <strong>small, solid, elevated lesio</strong>n less than 1 cm in diameter.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Unlike macules, papules <strong>project above the skin surface a</strong>nd&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Patch&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A patch is similar to a macule in that it is flat and has a color change, but by definition, a patch is <strong>larger than 1 cm</strong> in diameter.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vesicle&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A vesicle is a<strong> fluid-filled, circumscribed, elevated</strong> lesion <strong>less than 1 cm</strong> in diameter.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Vesicles form due to a split in the skin and contain <strong>clear fluid.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Primary lesions of the skin include:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Papule Plaque Nodule</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Vesicle Bulla</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Macule Patch</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Pustule Abscess</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Petechiae Purpura Ecchymosis</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Wheal</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:1200/683;width:97.57%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/14_Cw1spp4.jpg\" width=\"1200\" height=\"683\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:1200/648;width:97.57%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/16.jpg\" width=\"1200\" height=\"648\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:1200/682;width:96.11%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/17.jpg\" width=\"1200\" height=\"682\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:1200/726;width:94.88%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/18.jpg\" width=\"1200\" height=\"726\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:1200/575;width:93.45%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/19_GXA84eE.jpg\" width=\"1200\" height=\"575\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img class=\"image_resized\" style=\"aspect-ratio:900/859;width:92.34%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/20_EZN8nmV.jpg\" width=\"900\" height=\"859\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A <strong>macule</strong> is a <strong>flat, non-palpable, circumscribed lesion less than 1 cm</strong> in diameter that represents a <strong>change in skin color</strong> without alteration in skin texture or thickness.</span></li></ul>",
    "correct_choice_id": 316871,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6504,
    "choices": [
      {
        "id": 25985,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To prevent teratogenic effects </span></span></span></p>"
      },
      {
        "id": 25986,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To avoid failure of ATT </span></span></span></p>"
      },
      {
        "id": 25987,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Because rifampicin can decrease OCP metabolism </span></span></span></p>"
      },
      {
        "id": 25988,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Because rifampicin can induce OCP metabolism and cause failure</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female patient has been diagnosed with tuberculosis and is about to begin antitubercular therapy (ATT) that includes rifampicin. She is currently taking oral contraceptives (OCP) for birth control. The clinician advises her to use an additional barrier method of contraception while undergoing treatment. What is the primary reason for this recommendation?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
    "unique_key": "Q5541146",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947622,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Because rifampicin can induce OCP metabolism and cause failure</span></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rifampicin is used as one of the first line drugs against tuberculosis. Rifampicin is an enzyme inducer, that induces the cytochrome P450 enzymes. Therefore, this leads to increased rate of metabolism of the OCPs, thereby leading to contraceptive failure. So, in a female receiving ATT, it is advised to use additional barrier methods of contraception apart from OCPs.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. To prevent teratogenic effects</span></strong><span style=\"font-size:12.0pt\">: Most of the antitubercular drugs including rifampicin, isoniazid and ethambutol are safe in pregnancy. Further she is already taking OCPs, so the examiner does not want to ask about teratogenic effect of antitubercular drugs.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. To avoid failure of ATT</span></strong><span style=\"font-size:12.0pt\">: The interaction between ATT and OCP does not lead to the failure of antitubercular therapy; rather, it affects the efficacy of the oral contraceptive method.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Because rifampicin can decrease OCP metabolism</span></strong><span style=\"font-size:12.0pt\">: This is incorrect because rifampicin actually induces, rather than decreases, the metabolism of oral contraceptives. This can lead to reduced levels of contraceptive hormones in the blood, thereby potentially leading to contraceptive failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin is known to induce hepatic enzymes that speed up the metabolism of various drugs, including oral contraceptives. This can lead to lower blood levels of the hormones in OCPs, thereby reducing their efficacy and increasing the risk of contraceptive failure. Hence, it is advised for patients on both medications to use an additional barrier method of contraception.</span></span></span></p>",
    "correct_choice_id": 25988,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6506,
    "choices": [
      {
        "id": 25993,
        "text": "<p><span style=\"font-size:12.0pt;\">Premature closure of ductus arteriosus</span></p>"
      },
      {
        "id": 25994,
        "text": "<p><span style=\"font-size:12.0pt;\">Keeps ductus arteriosus patent</span></p>"
      },
      {
        "id": 25995,
        "text": "<p><span style=\"font-size:12.0pt;\">Closure of fossa ovalis</span></p>"
      },
      {
        "id": 25996,
        "text": "<p><span style=\"font-size:12.0pt;\">Premature closure of ductus venous</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman was prescribed indomethacin. Which of the following effects does the drug have on the fetus? (NEET PG 2021)</span></p>",
    "unique_key": "Q1635598",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947642,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Premature closure of ductus arteriosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indomethacin is an NSAID, that acts by inhibiting the Cyclooxygenase (COX) enzyme, thereby decreasing the synthesis of Prostaglandins. Prostaglandins are necessary for maintaining the patency of the ductus arteriosus in the fetus. Therefore, Indomethacin if given to a pregnant woman can lead to premature closure of the ductus arteriosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Keeps ductus arteriosus patent</strong>: Indomethacin does not keep the ductus arteriosus patent; instead, it promotes its closure by inhibiting prostaglandin synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Closure of fossa ovalis</strong>: The closure of the fossa ovalis is not influenced by indomethacin. The fossa ovalis is a different fetal structure that closes postnatally due to changes in pressure gradients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Premature closure of ductus venous</strong>: The ductus venosus closure is not affected by indomethacin. This structure typically closes naturally after birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indomethacin, an NSAID, can cause the premature closure of the ductus arteriosus in a fetus due to its inhibition of prostaglandin synthesis. Therefore, caution should be exercised when prescribing this drug to pregnant women, particularly in the third trimester.</span></p>",
    "correct_choice_id": 25993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55636,
    "choices": [
      {
        "id": 221989,
        "text": "<p><span style=\"font-size:12.0pt;\">Ewing\u2019s Sarcoma</span></p>"
      },
      {
        "id": 221990,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
      },
      {
        "id": 221991,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteochondroma</span></p>"
      },
      {
        "id": 221992,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteomyelitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old male presents with the following x-ray of knee. It is suggestive of: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105802_1c5JyIx.jpg\" width=\"311\" height=\"443\"></span></p>",
    "unique_key": "Q9094285",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947636,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Osteosarcoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The given image shows the <strong>Codman\u2019s triangle</strong> which is a characteristic radiological finding in <strong>osteosarcoma</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">Codman's triangle is&nbsp;a <strong>periosteal reaction</strong>, seen on&nbsp;X-ray, characterized by <strong>the lifting of the periosteum with a triangular piece of dense calcification</strong> underneath.&nbsp;</span></li><li><span style=\"font-size:16px;\">This appearance is indicative of an <strong>aggressive periosteal reaction</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">It is commonly associated with <strong>malignant lesions or chronic processes</strong>, with osteosarcoma being a typical example.</span></li><li><span style=\"font-size:16px;\"><strong>Sun Ray Appearance</strong> is another X-ray finding where there are <strong>multiple radiating spicules</strong> extending from a bone, <strong>resembling rays of the sun</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Note&nbsp;</strong>- While these periosteal reactions are highly suggestive of certain bone conditions, they are <strong>not diagnostic</strong> on their own. The definitive diagnosis of bone lesions, whether benign or malignant, is confirmed through a <strong>tissue biopsy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Ewing\u2019s Sarcoma:</strong> Ewing's sarcoma can show aggressive periosteal reactions such as an onion peel appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105818_pdaWlC8.jpg\" width=\"486\" height=\"340\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Osteochondroma:</strong> This is a benign bone growth that typically have a distinct appearance with an exostosis pointing away from the joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20105828.jpg\" width=\"527\" height=\"371\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Osteomyelitis:</strong> This condition can show a periosteal reaction, but it is usually a solid, narrow zone reaction and not the wide zone reaction like Codman's triangle.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Codman's triangle on an X-ray is a suggestive sign of osteosarcoma, a malignant bone tumor.</span></li></ul>",
    "correct_choice_id": 221990,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 80903,
    "choices": [
      {
        "id": 322296,
        "text": "<p><span style=\"font-size:12.0pt;\">Attention Deficit Hyperactivity Disorder (ADHD)</span></p>"
      },
      {
        "id": 322297,
        "text": "<p><span style=\"font-size:12.0pt;\">Specific Learning Disability (SLD)</span></p>"
      },
      {
        "id": 322298,
        "text": "<p><span style=\"font-size:12.0pt;\">Anxiety</span></p>"
      },
      {
        "id": 322299,
        "text": "<p><span style=\"font-size:12.0pt;\">PICA</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions is least likely to impair scholastic performance?</span><span style=\"font-size:16px;\"> (NEET PG 2016)</span></p>",
    "unique_key": "Q8082448",
    "question_audio": null,
    "question_video": null,
    "map_id": 23947639,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. PICA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PICA is an eating disorder characterized by the persistent consumption of non-nutritive, non-food substances (such as dirt, clay, paper, paint chips, etc.) that is inappropriate for the developmental level of the individual. While PICA can have health consequences due to ingestion of potentially harmful substances, it does not directly impact cognitive functions or learning abilities in the way the other listed conditions do. Therefore, PICA is least likely to directly impair scholastic performance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Attention Deficit Hyperactivity Disorder (ADHD) (Incorrect)</strong>: ADHD is characterized by inattention, hyperactivity, and impulsivity. These symptoms directly interfere with learning processes, classroom behavior, and academic achievement. Children with ADHD often struggle with focusing during lessons, completing assignments, following instructions, and staying organized, all of which significantly impact scholastic performance.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Specific Learning Disability (SLD) (Incorrect)</strong>: SLD is defined by significant impairment in one or more specific academic skills (reading, writing, mathematics) despite normal intellectual functioning. By definition, SLD directly impacts scholastic performance, as it specifically affects the acquisition and use of academic skills.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Anxiety (Incorrect)</strong>: Anxiety disorders can significantly impair scholastic performance through several mechanisms. Test anxiety can lead to underperformance in examinations, social anxiety can interfere with class participation and group activities, and generalized anxiety can affect concentration, working memory, and overall cognitive functioning in the classroom setting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When considering psychiatric disorders that impact academic performance, it's important to differentiate between conditions that directly affect cognitive functions, learning processes, or classroom behavior (like ADHD, learning disabilities, and anxiety) versus conditions that primarily affect other domains of functioning (like certain eating disorders). PICA, as an eating disorder characterized by consumption of non-food substances, has physiological and health implications but does not directly impact the cognitive processes essential for learning.</span></p>",
    "correct_choice_id": 322299,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00160 Mid Day Pyqs (Neetpg-1)';
        const quizFilename = '00160-mid-day-pyqs-neetpg-1-6d1ee2a8.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>